Araştırma Makalesi

The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department

Cilt: 4 Sayı: 3 10 Kasım 2022
PDF İndir
EN TR

The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department

Öz

Objective: The aim of this study is to evaluate the performance of CURB-65, Quick Sequential Organ Failure Assessment (qSOFA), and National Early Warning Score 2 (NEWS 2) scores in predicting mortality in COVID-19 patients in emergency department. Method: A total of 502 patients diagnosed with severe COVID-19 in the emergency department of a pandemic hospital were analyzed retrospectively. Demographic, clinical and laboratory data of the patients were obtained from the hospital registry system. The CURB-65, qSOFA, and NEWS2 scores of each patient were calculated separately. These patients were divided into two groups as those who survived and those who died. All parameters and calculated risk scores were statistically compared between these two groups. Results: While 281 out of 502 patients survived, 221 died. When the CURB-65, NEWS2, qSOFA scores were compared between the two patient groups, a significant difference was found (p<0.001 for all ). Compared with CURB-65 and qSOFA, sensitivity of 92.3% and NPV of 90.2% were detected when NEWS2≥8. The NEWS2 score reached the highest mortality predictive power among other scores with an AUC value of 0.86. Conclusion: Because the NEWS2 score is superior to CURB-65 and qSOFA for predicting mortality, it can be used in the triage of severe COVID-19 patients, predicting prognosis and improving outcomes.

Anahtar Kelimeler

Destekleyen Kurum

yok

Proje Numarası

yok

Teşekkür

yok

Kaynakça

  1. Donnelly CA, Fisher MC, Fraser C, Ghani AC, Riley S, Ferguson NM et al. Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect. Dis. 2004;4(11):672-83. doi. org/10.1016/S1473-3099(04)01173-9.
  2. Shi Y, Pandita A, Hardesty A, McCarthy M, Aridi J, Weiss Z.F et all. Validation of pneumonia prognostic scores in a statewide cohort of hospitalised patients with COVID-19. Int J Clin Pract. 2020;e13926. doi: 10.1111/ijcp.13926.
  3. Smith GB, Prytherch DR, Meredith P, Schmidt PE, Featherstone PI. The ability of the National early warning score (news) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013;84:465–70. doi: 10.1016/j.resuscitation.2012.12.016.
  4. Guo J , Zhou B, Zhu M, Yuan Y , Wang Q, Zhou H et al. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study. Epidemiol Infect. 2020;148:e241. doi: 10.1017/S0950268820002368.
  5. McGinley A, Pearse R. A national early warning score for acutely ill patients. BMJ. 2012;345:e5310. doi: 10.1136/bmj.e5310.
  6. Maitra S, Som A, Bhattacharjee S. Accuracy of quick sequential organ failure assessment (qSOFA) score and systemic inflammatory response syndrome (SIRS) criteria for predicting mortality in hospitalized patients with suspected infection: a metaanalysis of observational studies. Clin Microbiol Infect. 2018;24(11):1123–9. doi: 10.1016/j.cmi.2018.03.032.
  7. Liu S, Yao N, Qiu Y, He C. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease. Am J Emerg Med. 2020;38(10):2074-2080. doi: 10.1016/.ajem.2020.07.019.
  8. Ministry of Health, Republic of Turkey. Guidance to COVID-19(SARSCov2 infection). https://hsgm.saglik.gov.tr/depo/birimler/gocsagligi/covid19/rehber/COVID-19Rehberi20200414 eng v4 002 14.05.2020.pdf

Ayrıntılar

Birincil Dil

İngilizce

Konular

Acil Tıp

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

10 Kasım 2022

Gönderilme Tarihi

13 Ağustos 2022

Kabul Tarihi

6 Eylül 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 4 Sayı: 3

Kaynak Göster

APA
Ertekin, B., Yortanlı, M., Özelbaykal, O., Doğru, A., Girişgin, A. S., & Acar, T. (2022). The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phoenix Medical Journal, 4(3), 123-128. https://doi.org/10.38175/phnx.1161754
AMA
1.Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T. The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phnx Med J. 2022;4(3):123-128. doi:10.38175/phnx.1161754
Chicago
Ertekin, Birsen, Mehmet Yortanlı, Ozan Özelbaykal, Ali Doğru, Abdullah Sadık Girişgin, ve Tarık Acar. 2022. “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”. Phoenix Medical Journal 4 (3): 123-28. https://doi.org/10.38175/phnx.1161754.
EndNote
Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T (01 Kasım 2022) The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phoenix Medical Journal 4 3 123–128.
IEEE
[1]B. Ertekin, M. Yortanlı, O. Özelbaykal, A. Doğru, A. S. Girişgin, ve T. Acar, “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”, Phnx Med J., c. 4, sy 3, ss. 123–128, Kas. 2022, doi: 10.38175/phnx.1161754.
ISNAD
Ertekin, Birsen - Yortanlı, Mehmet - Özelbaykal, Ozan - Doğru, Ali - Girişgin, Abdullah Sadık - Acar, Tarık. “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”. Phoenix Medical Journal 4/3 (01 Kasım 2022): 123-128. https://doi.org/10.38175/phnx.1161754.
JAMA
1.Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T. The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phnx Med J. 2022;4:123–128.
MLA
Ertekin, Birsen, vd. “The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department”. Phoenix Medical Journal, c. 4, sy 3, Kasım 2022, ss. 123-8, doi:10.38175/phnx.1161754.
Vancouver
1.Birsen Ertekin, Mehmet Yortanlı, Ozan Özelbaykal, Ali Doğru, Abdullah Sadık Girişgin, Tarık Acar. The Performance of Risk Scoring Systems Used for Severe COVID-19 Cases in The Emergency Department. Phnx Med J. 01 Kasım 2022;4(3):123-8. doi:10.38175/phnx.1161754

Cited By

2392_ccby-295.jpg
Anka Tıp Dergisi  Creative Commons Atıf 4.0 Uluslararası Lisansı ile lisanslanmıştır.

2392_boai-189.jpg

Anka Tıp Dergisi Budapeşte Açık Erişim Deklarasyonu’nu imzalamıştır.